Patients with depression who received the Moodivate app saw clinically meaningful reductions in their symptoms that were ...

Beau Raymond, MD, elaborates on what successful patient-centered care entails, highlighting the role of patients to not only judge the success of their own care but also help guide clinicians as they ...

SALT LAKE CITY (KTVX) — When she first got her cancer diagnosis years ago ... the treatment room as Dukhi awaited the end of her infusion. “I’ve never had a patient receive 100 doses of any kind of ...

The first transplant of a genetically modified pig liver into a human was undertaken by Chinese researchers last year, according to a new, peer-reviewed study. The patient was clinically brain ...

First Patient Treated with HG-CT-1 CAR-T Therapy Passes Initial Safety Tests Hemogenyx Pharmaceuticals plc is pleased to announce that the first patient has been successfully treated as part of ...

Two CU Anschutz researchers have been working with researchers across the globe to develop groundbreaking new technology called adaptive deep brain stimulation. AURORA, Colo. — A medical breakthrough ...

The hospital used an advanced therapy called Lyfgenia, which modifies a patient's own bone marrow ... groundbreaking genetic treatment, he is the first person in New York to be cured of the ...

The GalaFlex Lite scaffold. [Image courtesy of BD] BD (NYSE: BDX) + announced today that investigators treated the first patient in a study of its GalaFlex Lite scaffold system. The FDA ...

Doctors at Northwell Health in New York used stem cell therapy Lyfgenia to cure sickle cell anemia for the first time. HealthDay News — For ... which modifies a patient’s own bone marrow to produce ...

Now that data is being linked with electronic medical records and analysed in an effort to predict medical problems and direct nurses' care – sometimes before they've evaluated the patient ...

The first patient has been dosed in a phase 2b trial evaluating the first-in-class agent Halneuron for those with neuropathic pain following chemotherapy. The first patient has been dosed in the phase ...

1 Recent data from newly diagnosed patients show that about 10% of those starting a novel therapy had an early relapse (within 12 months), while 28% had their first relapse within ... For example, a ...